@article{article, title = {{Vedolizumab for the Treatment of Adults with Moderate-to-Severe Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}}, publisher = {{Springer Science and Business Media LLC}}, url = {{http://eprints.whiterose.ac.uk/91088/ }}, year = {{2016}}, month = {{3}}, author = {{Essat M and Tappenden P and Ren S and Bessey A and Archer R and Wong R and Lobo A and Hoque S}}, doi = {{10.1007/s40273-015-0334-3}}, volume = {{34}}, journal = {{PharmacoEconomics}}, issue = {{3}}, pages = {{245-257}}, note = {{Accessed on 2025/08/13}}}